Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.


SARS-CoV-2 vaccine — think globally, act locally


In this preprint, Hassan et al. show that local immunization with the ChAd-SARS-CoV-2-S vaccine, based on a chimpanzee adenovirus, confers sterilizing protection in mice engineered to express human ACE2. Intramuscular delivery of ChAd-SARS-CoV-2-S protected against lung pathology but did not clear the infection of the upper respiratory tract after SARS-CoV-2 challenge. However, when administered intranasally, it induced local neutralizing antibody and T cell responses that provided superior protection to both the upper and lower respiratory tract, with no signs of viral replication 8 days post viral challenge. The presence of tissue-resident memory T cells in the lung suggested long-lasting protection. This work illustrates the importance of the delivery route to vaccine effectivity.


Original article

Download references

Author information

Authors and Affiliations


Corresponding authors

Correspondence to Ester Gea-Mallorquí or Ewoud B. Compeer.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Gea-Mallorquí, E., Compeer, E.B. SARS-CoV-2 vaccine — think globally, act locally. Nat Rev Immunol 20, 590 (2020).

Download citation

  • Published:

  • Issue Date:

  • DOI:

Further reading


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing